COVID-19, Psoriasis Patients
Conditions
Keywords
psoriasis, covid-19
Brief summary
A retrospective analysis based on database was conducted to evaluate the correlation between covid-19 infection and the condition and treatment of psoriasis patients.
Detailed description
Based on the patients registered in the psoriasis patient database of each center, the patients were followed up by telephone, and the severity of covid-19 infection, the change of psoriasis condition and the adjustment of treatment methods of psoriasis patients were collected for retrospective analysis.
Interventions
None listed
Sponsors
Gang Wang, MD
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
---- 1. No age limit, both male and female are accepted; 2. Psoriasis patients registered in the database; 3. Patients or their families can cooperate to complete the follow-up information survey (questionnaire, telephone, etc.) independently, and ensure the authenticity of the data provided.
Exclusion criteria
---- Patients are thought having conditions which are not appropriated for attending this clinical trial.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The recurrence/exacerbation of psoriasis following SARS-CoV-2 infection | March 15,2023 to May 30,2023 | The impact of SARS-CoV-2 infection on psoriasis in patients receiving different baseline therapies of psoriasis. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Univariate and multivariate analyses identify risk factors with psoriasis exacerbation/recurrence after SARS-CoV-2 infection | March 15,2023 to May 30,2023 | Univariate and multivariate analyses identify risk factors with psoriasis exacerbation/recurrence after SARS-CoV-2 infection |
Countries
China
Contacts
Primary ContactGANG WANG, M.D.
Backup ContactCHEN YU
Outcome results
None listed